The Czechia is looking forward to the approval of the covid-19 vaccine from Novavax, and has ordered 370,000 doses. This was stated by the Minister of Health Adam Vojtěch (for YES) after today's government meeting. The vaccine of the American company is currently being evaluated by the European Medicines Agency (EMA). If the vaccine is approved, Vojtěch expects the delivery in January.
Novavax protein vaccine works on a different principle than Pfizer / BioNTech or Johnson & Johnson preparations and uses technology already used, for example, in flu and cervical cancer vaccines.
"This vaccine could be an alternative for people who, for some reason, although it is often based on various misinformation, do not have the will to be vaccinated with the existing vaccines," Vojtěch said about the Novavax preparation.
Novavax applied to the European Agency for approval of its preparation on 17 November. The EMA could issue a possible recommendation within a few weeks, after which the vaccine must be approved by the European Commission for use in the EU. The Novavax vaccine would thus become the fifth approved in the EU - vaccines from Moderna, Johnson & Johnson, AstraZeneca and Pfizer / BioNTech have so far been recommended for conditional registration.
EMA is also assessing another protein vaccine from the French manufacturer Sanofi, which, according to Vojtěch, the Czechia has also ordered. The Minister of Health also mentioned a preparation from the French company Valneva, the effectiveness of which is now being assessed by the EMA. However, according to the Minister of Health, due to the fact that this vaccine is still in the initial stages of approval, the Czech Republic is not yet dealing with the order. According to him, it would be available in April or May of the following year at the earliest.
Video Head of the Association of Nurses Šochmanová: Rejectors among paramedics are hugely illegal. Mandatory vaccination makes sense. - Markéta Volfová, Lukáš Červený